Wyeth To Challenge U.K. Effexor Restrictions
This article was originally published in The Pink Sheet Daily
Executive Summary
Effective Dec. 6, U.K. labeling for Effexor contraindicates the antidepressant in patients with cardiovascular disease, recommends a baseline ECG for new patients, and restricts prescribing to specialists. Wyeth intends to file a formal appeal of the decision within two weeks.